| Literature DB >> 33289470 |
Christine M Hughes1, Lindy Liu2,3, Whitni B Davidson1, Kay W Radford4, Kimberly Wilkins1, Benjamin Monroe1, Maureen G Metcalfe3, Toutou Likafi5, Robert Shongo Lushima6, Joelle Kabamba7, Beatrice Nguete5, Jean Malekani8, Elisabeth Pukuta9, Stomy Karhemere9, Jean-Jacques Muyembe Tamfum9, Emile Okitolonda Wemakoy5, Mary G Reynolds1, D Scott Schmid4, Andrea M McCollum1.
Abstract
Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo, where MPX is endemic, has uncovered multiple cases of MPX and varicella zoster virus (VZV) coinfections. The purpose of this study was to verify if coinfections occur and to characterize the clinical nature of these cases. Clinical, epidemiological, and laboratory results were used to investigate MPX/VZV coinfections. A coinfection was defined as a patient with at least one Orthopoxvirus/MPX-positive sample and at least one VZV-positive sample within the same disease event. Between September 2009 and April 2014, 134 of the 1,107 (12.1%) suspected MPX cases were confirmed as MPX/VZV coinfections. Coinfections were more likely to report symptoms than VZV-alone cases and less likely than MPX-alone cases. Significantly higher lesion counts were observed for coinfection cases than for VZV-alone but less than MPX-alone cases. Discernible differences in symptom and rash severity were detected for coinfection cases compared with those with MPX or VZV alone. Findings indicate infection with both MPX and VZV could modulate infection severity. Collection of multiple lesion samples allows for the opportunity to detect coinfections. As this program continues, it will be important to continue these procedures to assess variations in the proportion of coinfected cases over time.Entities:
Mesh:
Year: 2020 PMID: 33289470 PMCID: PMC7866336 DOI: 10.4269/ajtmh.20-0589
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 3.707